Stock Price & Overview 64.28K followers $84.05-0.15 (-0.18%)4:00 PM 03/13/25 NASDAQ |$USD |Post-Market:$83.76-0.29 (-0.35%)7:34 PM ILMN Analysis Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race ...
Use Futu NiuNiu to view Illumina (ILMN)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
Current Price $36.19 NASDAQ: GILD Gilead Sciences Market Cap $130B Current Price $104.54 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
Analyze Illumina, Inc. (ILMN) and its peers with detailed stock momentum insights. Compare performance trends over time to track market dynamics effectively.
Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay...
Bank of America lowers the Target Price for Illumina to $75. Bank of America: Downgraded Illumina's Target Price from $90 to $75, maintaining a "underperforming Large Cap" rating. (Gelonghui) Gelonghui FinanceApr 15 17:34· Ratings Piper Sandler Maintains Illumina(ILMN.US) With Buy Rating,...
Illumina, Inc. Common Stock (ILMN) Historical NOCP 5D 1 M 3 M 6 M 1 A *Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours.Nasdaq Official Closing Price (NOCP) » est un processus permettant d’...
Moving to cash flow and balance sheet items for the quarter. Cash flow provided by operations was $364 million. Capital expenditures were $42 million and free cash flow was $322 million. In Q4, we repurchased 134,000 shares of alumina stock for $17 million at an average price of $129 ...
做生命科学投资的同学一定都知道基因检测龙头$Illumina(ILMN)$7年15倍的传奇故事,错过的一定后悔不已。现在有更好的机会就在眼前,看看我们是否能抓住了! 7年15倍,多么惊艳的曲线-- ILMN 在创立ILMN对基因检测技术革命后,抱着要对作为生命基础的蛋白质检测技术进行革命的使命,12年前ILMN的创始人之一技术大拿David...
which include stock-based compensation. I encourage you to review the GAAP reconciliation of these non-GAAP measures, which can be found in today’s release and in supplementary data available on our website. In the second quarter, consolidated revenue was $1.16 billion, up 3% year-over-year...